We have a strong R&D team who is experienced in the pharmaceutical industry and is specialised in fields such as medicinal chemistry, pharmacy, pharmacology and product development.
We have been conducting research and development on pharmaceutical products for liver and digestive system related conditions for the past 11 years. We believe that we possess the necessary scientific expertise and know-how in this aspect of medical science.
The objectives of our research and development efforts are as follows
-
Development of new applications forexisting pharmaceutical products -
Development of new pharmaceutical products -
Improvement on our production process.
Currently, our focus is on developing an improved version of ATT tablets. We have applied for patents in the PRC for the application of ATT for fatty liver and liver diseases arising from the consumption of alcohol. We have obtained the patent in the PRC for our technology used in the production of ATT capsules and we have been given the approval of the SFDA to commence production of ATT capsules.
We are also conducting research on the usage of more advanced technology in isolating and finding new active ingredients in Ganhuangcao. We have also made improvements in the bioavailability of the ATT tablets. This enables the body to absorb the drug faster than the previous versions of our product. We also intend to apply for a patent for the production of ATT for injections in the PRC.
In addition, we are currently conducting research and development on Ganhuangcao (raw material of Gansu) due to their positive effects on many liver patients.
